Cytokinetics (NASDAQ:CYTK) is set to give its latest quarterly earnings report on Tuesday, 2026-02-24. Here’s what investors need to know before the announcement.
Analysts estimate that Cytokinetics will report an earnings per share (EPS) of $-1.41.
The announcement from Cytokinetics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It’s worth noting for new investors that guidance can be a key determinant of stock price movements.
Performance in Previous Earnings
The company’s EPS beat by $0.04 in the …